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Abstract One-step lateral ﬂow test is recommended as
the ﬁrst line screening of syphilis for primary healthcare
settings in developing countries. However, it generally
shows low sensitivity. We describe here the development
of a novel ﬂuorescent POC (Point Of Care) test method to
be used for screening for syphilis. The method was
designed to combine the rapidness of lateral ﬂow test and
sensitiveness of ﬂuorescent method. 50 syphilis-positive
specimens and 50 healthy specimens conformed by Trep-
onema pallidum particle agglutination (TPPA) were tested
with Quantum Dot-labeled and colloidal gold-labeled lat-
eral ﬂow test strips, respectively. The results showed that
both sensitivity and speciﬁcity of the quantum dots–based
method reached up to 100% (95% conﬁdence interval [CI],
91–100%), while those of the colloidal gold-based
method were 82% (95% CI, 68–91%) and 100% (95% CI,
91–100%), respectively. In addition, the naked-eye detec-
tion limit of quantum dot–based method could achieve
2 ng/ml of anti-TP47 polyclonal antibodies puriﬁed by
afﬁnity chromatography with TP47 antigen, which was
tenfold higher than that of colloidal gold–based method. In
conclusion, the quantum dots were found to be suitable for
labels of lateral ﬂow test strip. Its ease of use, sensitiveness
and low cost make it well-suited for population-based
on-the-site syphilis screening.
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Introduction
Lateral ﬂow test, one of the most common Point-Of-Care
(POC) test formats, is well-known via home pregnancy test
strips and widely applied into qualitative or semi-quanti-
tative detection of numerous analytes including antibodies,
viruses, bacteria, nucleic acid, antibiotics, speciﬁc bio-
markers, and even pesticide [1–7]. The lateral ﬂow test was
ﬁrst introduced as a popular platform for rapid test in late
1980s. Since then, it has been developing rapidly and
playing an important role in POC test market. Traditional
lateral ﬂow tests use colloidal gold, dye, or latex bead
conjugates to generate visual signal [7]. Compared with
core laboratory test formats, lateral ﬂow test has clear
advantages in ease of use, rapid result and portability,
making it well-suited for operation at the site of patient
care [8].
As reported previously, although rapid POC test was
less sensitive than laboratory-based tests, it could facilitate
the treatment of those patients infected with sexually
transmitted infections (STIs) better than laboratory-based
tests [9]. It is well known that STIs are very common in
developed and developing countries. Sexually transmitted
diseases are regarded as one of the ﬁrst ten causes of
unpleasant diseases in young male adults in developing
countries and the second major cause of unpleasant
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DOI 10.1007/s11671-010-9578-1diseases in young female adults [10]. Especially syphilis
brought approximate 12 million new cases and the major-
ity occurred in developing countries with limited labora-
tory services [9]. Therefore, the cheap and rapid POC tests
may be taken as the ﬁrst line screening formats for syphilis.
Because the inherent limitation of traditional gold-based
lateral ﬂow test strips causes its limited sensitivity,
researchers have been working on different tags, including
enzyme, silver enhancement, chemiluminescent tags or
ﬂuorescent tags, in hopes of increasing sensitivity [11].
Quantum dots have been subject to intensive investi-
gations due to their unique photoluminescence properties
and potential application prospect [12]. So far, several
methods have been developed to synthesize water-soluble
quantum dots for use in biological relevant studies [13].
For example, quantum dots have been used successfully in
cellular imaging [14, 15], immunoassays [16, 17], biosen-
sor [18] and optical barcoding [19]. Quantum dots are also
used to study the interaction between protein molecules or
detect the course of signal transduction in live cells by
Fluorescence Resonance Energy Transfer (FRET) [20, 21].
Quantum dots provide a new functional platform for bio-
analytical sciences and biomedical engineering.
Herein, we describe the development and evaluation of a
novel QDs-based lateral ﬂow test for the rapid screening of
syphilis, which is economical, easy to use and retains the
high sensitivity of ﬂuorescent dyes. Furthermore, this novel
ﬂuorescent tag has incomparable advantages in terms of
size-dependent ﬂuorescence, broad absorption spectra and
narrow emission spectra, excellent photostability over tra-
ditional organic dyes, and has great potential application in
clinical disease quick diagnosis.
Materials and Methods
Clinical Samples
Informed consent was obtained from patients, and this
study was approved by the Medical Ethics Committee of
No.261 Hospital of PLA. Human experimentation guide-
lines of the No.261 Hospital of PLA were followed in the
conduct of clinical research. Fifty TPPA-positive serum
samples collected from September 2007 to May 2008 in
Center of Biological Diagnosis and Therapy of No.261
Hospital of PLA, China, were selected for this study. The
gold standard we selected for a ‘‘true positive sample’’ was
deﬁned as a sample with a TPPA titer of 1: 80 or above and
a positive Fluorescent Treponemal Antibody Absorption
result (FTA-Abs). The negative control group consisted of
50 healthy TPPA-negative and FTS-Abs negative sera from
volunteer blood donors. All of the samples were collected
in an anonymous manner, and the exact clinical status or
drug usage of the patients was unknown. After being
collected, the samples were kept at -70C refrigerator
until further use.
Materials
Thioglycolic acid (TGA), sodium borohydride and carbo-
diimide hydrochloride (EDC), chloroauric acid, Staphylo-
coccal Protein A (SPA) are purchased from Sigma (Sigma.
USA) and were used without further treatment or puriﬁca-
tion. The nitrocellulose membrane was purchased from
Amersham. Human immunoglobulin G (IgG) and TP15,
TP17, TP47 recombinant syphilis antigen, as well as bovine
serum albumin (BSA), were purchased from Linchao Bio-
technology (Linchao. China). All synthetic preparations and
measurements were carriedoutinMilliporewater assolvent
with 18 MX/cm or less. All other analytically puriﬁed
reagents were purchased domestically.
Preparation of Quantum Dots
About 5 mmol of CdCl25H2O was dissolved in 110 mL of
water, and 12 mM of TGA was added under stirring. The
pH of resultant solution was adjusted to 11 by dropwise
addition of 1 M NaOH solution. The solution was then
transferred into a three-necked ﬂask and deaerated by N2
bubbling for 30 min. Under stirring, 2.5 mM of oxygen-
free NaHTe solution, which was freshly prepared from
tellurium powder and NaBH4 (molar rate of 1: 2) in water
at 0C, was injected into the three-necked ﬂask. After
reﬂux at 100C for 4 h, the 3.5 nm diameters TGA-capped
CdTe QDs emitted with a maximum wavelength around
610 nm were synthesized. The obtained QDs were puriﬁed
by precipitation in ethanol and redispersed in PBS.
Absorbance spectrum and photoluminescence (PL) spec-
trum were used to characterize the ﬂuorescent properties of
QDs; they were measured in 1-cm quartz in air at room
temperature using a LabTech UV2000 ultraviolet spectro-
photometer and Perkin Elmer LS 55 spectroﬂuorimeter.
The size determination of QDs was performed using a
transmission electron microscope (TEM, JEM2010, at
200 kV). Its size distributions were obtained by measuring
QDs of the TEM image which had more than 300
nanoparticles.
Preparation of Colloidal Gold
About 15 nm monodisperse colloidal gold particles were
prepared according to the method described before by the
authors [22]. Brieﬂy, 50 mL (0.2 mg/mL) chloroauric acid
was heated to boiling point, and then 1.2 mL (10 mg/mL)
sodium citrate was added. Boiling lasted 5 min until it
became dark red in color. After cooling down to room
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123temperature, 20 lL of colloidal gold were used for the
analysis of transmission electron microscope. Its size dis-
tributions were measured in the same way as mentioned in
QDs section.
Conjugation of SPA with QDs and Colloidal Gold
Firstly, 5 mL of 3 mg/mL QDs and 5 mL of 0.05, 0.1, 0.2,
0.4, 0.8 mg/mL SPA were mixed, respectively, and then
0.5 mL 1 mg/mL EDC were added and blended by vortex.
The resulting solution reacted at room temperature for 3 h
with continuous mixing and then at 4C for 24 h. BSA was
added into the solution at a concentration of 5 mg/mL and
incubated at room temperature for 3 h. The QDs-labeled
SPAs were then centrifuged at 15,000g for 30 min and the
supernatant was discarded. A volume of 10.5 mL PBST
[Phosphate-Buffered Saline (PBS); 0.2 mg/mL KCl,
1.44 mg/mL Na2HPO4, 0.24 mg/mL KH2PO4, 8 mg/mL
NaCl, pH 7.4] with 0.5% tween-20 (v/v) was used to
resuspend and wash QDs-labeled SPA by centrifugation at
15,000g for three times. Finally, the QDs-labeled SPA
were dispersed in 105 mL PBST and kept at 4C until use.
The as-prepared colloidal gold was regulated to pH 8.0
with 0.1 mol/L K2CO3. Under magnetic stirring, the ﬁnal
concentration of 12.5, 25, 50, 100, 200 lg/mL SPA was
added, respectively. After 10 min, BSA was added to
obtain a concentration of 10 mg/mL. The resultant mixture
was centrifuged at 2,500g for 5 min. The supernatant was
transferred to a new centrifuge tube and centrifuged at
12,000g for 20 min. The precipitate was dissolved by PBS
containing 5 mg/mL BSA and then stored at 4C.
Preparation of Lateral Flow Test Strips
The mixture of TP15, TP17 and TP47 recombinant syphilis
antigen was dispensed on the nitrocellulose membrane with
Biodot XYZ3000 dispenser at concentration of 1 mg/mL of
each as test line. IgG was dispensed at concentration of
0.5 mg/mL as control line. After drying for 30 min, the
nitrocellulose membrane was blocked with PBS containing
1% BSA (w/v). The Colloidal gold conjugates were printed
on conjugate pad at optimized concentration described later
and dried at room temperature. Absorbent pad, nitrocellu-
lose membrane, conjugate pad and sample pad were pasted
on the laminating card in order with proper overlapping
distance. Then the whole card was cut into ﬁnal test strips
of 4 mm in width with guillotine cutter. The preparation of
QD-based test strips was slightly different from colloidal
gold–based test strips in their lamination (Fig. 1).
Optimization of Labeling with QDs and Colloidal Gold
The control line of test strips was used to determine the
optimum amount of labeling. For the optimization of
labeling amount of SPA, QDs and colloidal gold labeling
different concentration of SPA were used. The colloidal
gold test strips were inserted into 1.5-mL test tubes con-
taining 200 lL PBS and the coloring of control line was
observed after 10 min. The QD-based test strips were
inserted into 1.5 mL test tubes containing 200 lLo f
QD-labeled SPA solution and the coloring of control line
was observed after 10 min. A slight difference was that the
results of QDs-based test strips were observed under the
portable ultraviolet lamp.
Fig. 1 The schematic drawing
of QD-based lateral ﬂow test
strips
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The anti-TP47 polyclonal antibodies puriﬁed by afﬁnity
chromatography with TP47 antigen were a kind gift from
associate Prof. Ding Li. Upon receipt, the polyclonal
antibodies were quantiﬁed by absorbance at 280 nm and
diluted tenfold serially from 2 lg/mL to 0.2 ng/mL. Those
polyclonal antibodies were used to determine the naked-
eye limit of detection of both colloidal gold-based and
QDs-based test strips.
Test of Clinical Samples
The test group and negative control group were tested with
colloidal gold–based and QDs-based test strips, respec-
tively, and the performance of the two labels was analyzed
with Statistics Package for Social Sciences (SPSS) soft-
ware (SPSS Inc, Chicago, USA).
Results and Discussion
The diameter and size distribution of as-prepared colloidal
gold and CdTe QDs synthesized in this work were deter-
mined by TEM. A representative example was presented in
Fig. 2. The mean diameter of colloidal gold is about 15 nm
and that of QDs is about 3.5 nm (Fig. 3). The absorbance
spectrum, ﬂuorescence spectrum and images of QDs before
and after the coupling with SPA under UV irradiation is
shown in Fig. 4. It is showed that the QDs could be excited
effectively under ultraviolet band and their maximum ﬂuo-
rescence wavelength was at around 610 nm before conju-
gation and shifted to around 596 nm after conjugation.
According to the coloring of colloidal gold–based test
strips, the concentration of 50 lg/mL presented the stron-
gest red control line. Under or above this concentration
would decrease the coloring. Therefore, 50 lg/mL was the
best concentration for labeling of colloidal gold. Similarly,
QDs-capped SPA prepared with 0.2 mg/mL exhibited the
strongest ﬂuorescence intensity and thus this concentration
was determined as best one for labeling of QDs. In this
work, the naked-eye limit of detection of colloidal gold–
based lateral ﬂow test strips could only reach 20 ng/mL of
anti-TP47 polyclonal antibody solution, whereas that of
QDs-based test strips could easily reach 2 ng/mL of anti-
TP47 polyclonal antibody solution, tenfold higher than that
of colloidal gold test strips.
Out of the 50 TPPA-positive samples, 9 samples were
false negative in the colloidal gold–based lateral ﬂow test
strips, resulting in an overall sensitivity of 82%, with a
95% conﬁdence interval (CI) (scored by Wilson’s method
[23]) of 68–91% (Table 1). The TPPA titer of 9 false
negative samples was below or equal to 1: 160. However,
its speciﬁcity was 100% (95% CI, 91–100%). Both sensi-
tivity and speciﬁcity of QDs-based test strips were 100%
(95% CI, 91–100%). The typical test results were shown in
Fig. 5.
In this study, we report a simple and sensitive QDs-
based rapid detection method for syphilis antibody. Its test
result was compared with that of colloidal gold–based
rapid test strips. Regarding the colloidal gold–based rapid
immunochromatographic test, the sensitivity of 82% (95%
CI, 68–91%) was obtained in 50 known syphilis-positive
sera, which is accordant to the assertion that one-step
immunochromatographic rapid test was not sufﬁciently
sensitive [24]. In particular, it is often difﬁcult to interpret
in some weakly positive sera. Owing to its ease to perform,
one-step lateral ﬂow test is still recommended for primary
healthcare settings in developing countries. However,
limited equipments for reserve and insufﬁcient training in
developing countries may cause the worrisomely low
sensitivity. According to Zhi-qiang Chen et al., the total
incidence of primary and secondary syphilis in China, 5.7
cases per 100,000 in 2005, was reported, much higher than
that in most developed countries [25]. If some of those
patients seek care from ill-equipped private clinical setting,
Fig. 2 Characterization of QDs
(a) and colloidal gold (b)b y
transmission electron
microscopy
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123the consequence of misdiagnosis caused by the low sen-
sitivity of colloidal gold–based lateral ﬂow test strips
would be devastating. In contrast with traditional lateral
ﬂow test strips, Enzyme-Linked ImmunoSorbent Assay
(ELISA) was cried up for its excellent sensitivity. But its
complicated and lengthy operation makes it not suitable for
the ﬁrst line screening or on-site screening of syphilis. In
addition, as for colloidal gold–based rapid test strips,
another problem is the interference of hemolytic serum.
The coloring is difﬁcult to distinguish in some cases when
hemolysis occurs. In order to resolve these problems,
ﬂuorescence or other labels have been taken into consid-
eration [11]. However, conventional ﬂuorescent dyes suffer
from some limits including narrow excitation spectrum,
poor photostability and short ﬂuorescent lifetime, all of
which greatly restrict the application of those ﬂuorescent
dyes in lateral ﬂow test strips [26].
QDs, as a novel class of inorganic ﬂuorophore, have
attracted more and more attention and substantial progress
has been made in utilization of QDs as a kind of biological
label [13, 17]. The efﬁcient ﬂuorescence and stability of
QDs can improve sensitivity and prolong lifetime in its
usage as a biological label. Unlike other ﬂuorophores that
have narrow excitation range, semi-conductor QDs have
broad absorbance bands. This property allows the excita-
tion of QDs at a broad wavelength range, that is, no
requirement of special light source equipment with a
speciﬁc excitation wavelength. Photostability is a singular
advantage that QDs have. The traditional organic ﬂuoro-
phores bleach after only a few minutes on exposure to
light, whereas QDs are extremely stable and can undergo
repeated cycles of excitation and ﬂuorescence for hours
with a high level of brightness and photobleaching
threshold and thus this characterization endows QDs with
pretty high sensitivity [27]. As previously reported, QDs
were more photostable than a number of organic dyes
including Alexa 488, which is reported to be the most
stable organic dye [26–29].
In our study, the as-prepared QDs had a fairly broad
excitation spectrum, which meant that a cheap and portable
325-nm UV lamp could be used as effective excitation
source. Besides, the blue shift occurred after the coupling
of QDs with SPA and the bright red ﬂuorescence of QDs
turned dark red. The probable reason is that the carboxyl
group on the surface of QDs was covalently combined with
the amino group of SPA, which reduced the surface charge
of QDs, decreased the polarization rate of the surrounding
molecules and reduced the Stokes displacement, ﬁnally
resulting in a blue shift in the emission spectra [30].
Meanwhile, the full width at half maximum (FWHM) of
the QDs and QDs-labeled SPA remained constant, which
Fig. 3 Size distributions of QDs (a) and colloidal gold (b)
Fig. 4 UV–vis absorption spectra (a) and PL spectra (b) of QDs
Nanoscale Res Lett (2010) 5:875–881 879
123suggested that no aggregation happened to the QDs in the
coupling process. According to the clinical performance of
the methods based on these two labels, the QDs-based test
strips showed much higher sensitivity than colloidal
gold–based test strips.
Despite the satisfying results, there is a need for further
studiestoestimate thediagnosticaccuracyoftheQDs-based
lateral ﬂowteststrip in patients with suspected infectionand
with positive serologic test results, and patients with other
pathologic conditions. Besides, a multi-centric study in
which the same samples are evaluated would be highly
valuable. Moreover, it was very difﬁcult to take clear ﬂuo-
rescentphotosunderultravioletlampbythenonprofessional
digital cameraweusedandtherefore ourgroupisworkingat
a kind of mini-reader with ultraviolet source and a minia-
turizedprofessionalcharge-coupleddevice(CCD).Wehope
to take clear ﬂuorescent photographs of QDs-based lateral
ﬂow test strips for qualitative and quantitative analysis by
this reader. With this equipment, we will be able to obtain a
more accurate and objective result.
Conclusions
In conclusion, we have developed a novel ﬂuorescent POC
rapid test method to be used for screening for syphilis that
is inexpensive, easy to perform, and has been demonstrated
to be suitable for on-the-site syphilis screening. Its clinical
performance in clinical tests could make it a promising
replacement for colloidal gold–based lateral ﬂow test
strips.
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